articleA proof-of-concept nanorobot design could be used to target cancer…
7 January 2020 | By Hannah Balfour (European Pharmaceutical Review)
A proof-of-concept nanorobot design could be used to target cancer cells by their glucose consumption and deliver a drug payload in response to tumour interaction.